Single cell-resolution in situ sequencing elucidates spatial dynamics of multiple sclerosis lesion and disease evolution
暂无分享,去创建一个
G. Castelo-Branco | E. Agirre | C. Yokota | A. O. Guerreiro-Cacais | T. Olsson | C. Langseth | M. Nilsson | M. Hilscher | P. Kukanja | K. Tiklova | L. A. Rubio Rodríguez-Kirby | A. Raman | C. Avenel
[1] Alexander R. Pico,et al. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling , 2023, Nature Immunology.
[2] D. Gosselin,et al. Roles and regulation of microglia activity in multiple sclerosis: insights from animal models , 2023, Nature Reviews Neuroscience.
[3] L. Alfredsson,et al. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis , 2023, Science advances.
[4] T. Kuhlmann,et al. Inflammation in multiple sclerosis: consequences for remyelination and disease progression , 2023, Nature Reviews Neurology.
[5] M. Kerschensteiner,et al. Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex , 2023, Neuron.
[6] Hanseul Park,et al. Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice , 2023, Nature Communications.
[7] Christopher J. Bohlen,et al. Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease , 2023, Nature Neuroscience.
[8] L. Steinman,et al. Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease , 2023, The Journal of experimental medicine.
[9] B. McColl,et al. Microglia regulate central nervous system myelin growth and integrity , 2022, Nature.
[10] J. Ragoussis,et al. Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis , 2022, Neurology: Neuroimmunology & Neuroinflammation.
[11] Miguel A. Ibarra-Arellano,et al. Spatial cell type mapping of multiple sclerosis lesions , 2022, bioRxiv.
[12] M. Simons,et al. CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging , 2022, Nature Neuroscience.
[13] Trygve E Bakken,et al. Transcriptomic diversity of cell types across the adult human brain , 2022, bioRxiv.
[14] J. Saez-Rodriguez,et al. Cross-regional homeostatic and reactive glial signatures in multiple sclerosis , 2022, Acta Neuropathologica.
[15] Sergio Marco Salas,et al. Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma , 2022, bioRxiv.
[16] M. Plikus,et al. Screening cell–cell communication in spatial transcriptomics via collective optimal transport , 2022, bioRxiv.
[17] Tracy J. Yuen,et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. , 2022, Cell reports.
[18] I. Amit,et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies , 2022, Nature Neuroscience.
[19] Peng Tan,et al. Spatial Atlas of the Mouse Central Nervous System at Molecular Resolution , 2022, bioRxiv.
[20] José Fernández Navarro,et al. Identification of early neurodegenerative pathways in progressive multiple sclerosis , 2022, Nature Neuroscience.
[21] R. Adams,et al. Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain , 2022, bioRxiv.
[22] D. Perl,et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation , 2022, Cell.
[23] Markus M. Hilscher,et al. Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes , 2022, BMC Biology.
[24] Mats F. Nilsson,et al. Direct RNA targeted in situ sequencing for transcriptomic profiling in tissue , 2022, Scientific Reports.
[25] O. Elemento,et al. Unsupervised discovery of tissue architecture in multiplexed imaging , 2022, bioRxiv.
[26] Fabian J Theis,et al. Spatial components of molecular tissue biology , 2022, Nature Biotechnology.
[27] Erik L. G. Wernersson,et al. Deconwolf enables high-performance deconvolution of widefield fluorescence microscopy images , 2022 .
[28] Thomas E. Nichols,et al. How patients with multiple sclerosis acquire disability , 2022, Brain : a journal of neurology.
[29] Fabian J Theis,et al. Squidpy: a scalable framework for spatial omics analysis , 2022, Nature Methods.
[30] Mark S. Anderson,et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM , 2022, Nature.
[31] S. Elledge,et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.
[32] M. Gerstung,et al. Cell2location maps fine-grained cell types in spatial transcriptomics , 2022, Nature Biotechnology.
[33] C. Granziera,et al. Smouldering multiple sclerosis: the ‘real MS’ , 2022, Therapeutic advances in neurological disorders.
[34] V. Yong,et al. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis , 2021, Nature Reviews Neurology.
[35] Evan Z. Macosko,et al. Deep learning and alignment of spatially resolved single-cell transcriptomes with Tangram , 2021, Nature Methods.
[36] W. Richardson,et al. G protein‐coupled receptor GPR37‐like 1 regulates adult oligodendrocyte generation , 2021, Developmental neurobiology.
[37] Ariel J. Levine,et al. A harmonized atlas of mouse spinal cord cell types and their spatial organization , 2021, Nature Communications.
[38] D. Reich,et al. A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis , 2021, Nature.
[39] N. Friedman,et al. NovoSpaRc: flexible spatial reconstruction of single-cell gene expression with optimal transport , 2021, Nature Protocols.
[40] J. Kira. Redefining use of MRI for patients with multiple sclerosis , 2021, The Lancet Neurology.
[41] M. Duddy,et al. COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies , 2021, Multiple Sclerosis and Related Disorders.
[42] Jeremy L. Muhlich,et al. Stitching and registering highly multiplexed whole-slide images of tissues and tumors using ASHLAR , 2021, bioRxiv.
[43] J. Shu,et al. ClusterMap: multi-scale clustering analysis of spatial gene expression , 2021, bioRxiv.
[44] Kira E. Poskanzer,et al. Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.
[45] R. Franklin,et al. Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits? , 2021, Open Biology.
[46] Markus M. Hilscher,et al. Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury , 2020, Nature Communications.
[47] O. Harismendy,et al. Deciphering cell–cell interactions and communication from gene expression , 2020, Nature reviews. Genetics.
[48] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[49] Joseph Bergenstråhle,et al. Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography , 2020, Communications Biology.
[50] Sergio Marco Salas,et al. Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue , 2020, Nucleic acids research.
[51] Trygve E Bakken,et al. NS-Forest: A machine learning method for the objective identification of minimum marker gene combinations for cell type determination from single cell RNA sequencing , 2020, bioRxiv.
[52] K. Kuter,et al. Overview of General and Discriminating Markers of Differential Microglia Phenotypes , 2020, Frontiers in Cellular Neuroscience.
[53] Lihua Zhang,et al. Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.
[54] Anna C. Williams,et al. New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination , 2020, Nature Neuroscience.
[55] O. Lindvall,et al. Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions , 2020, Nature Communications.
[56] J. Ragoussis,et al. MAFG-driven astrocytes promote CNS inflammation , 2020, Nature.
[57] Christopher C. Overall,et al. The active contribution of OPCs to neuroinflammation is mediated by LRP1 , 2019, Acta Neuropathologica.
[58] C. Welle,et al. Motor Learning Promotes Remyelination via New and Surviving Oligodendrocytes , 2020, Nature Neuroscience.
[59] D. Holtzman,et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease , 2020, Nature Medicine.
[60] Yumeng Zhang,et al. Characterization of a long noncoding RNA Pcdh17it as a novel marker for immature premyelinating oligodendrocytes , 2019, Glia.
[61] K. Harris,et al. Probabilistic cell typing enables fine mapping of closely related cell types in situ , 2019, Nature Methods.
[62] D. Reich,et al. Potential role of iron in repair of inflammatory demyelinating lesions. , 2019, The Journal of clinical investigation.
[63] Kyle A. Martin,et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination , 2019, Nature Communications.
[64] P. Nilsson,et al. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk , 2019, Proceedings of the National Academy of Sciences.
[65] Reiji Yamazaki,et al. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye , 2019, Proceedings of the National Academy of Sciences.
[66] O. Ciccarelli,et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines , 2019, Brain : a journal of neurology.
[67] Richard Reynolds,et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis , 2019, Nature.
[68] J. Dunn,et al. Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis , 2019, Scientific Reports.
[69] Fabian J Theis,et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells , 2019, Genome biology.
[70] Sagar,et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution , 2019, Nature.
[71] O. Ciccarelli,et al. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord , 2019, Brain : a journal of neurology.
[72] Tuan Leng Tay,et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation , 2019, Science.
[73] D. Malhotra,et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis , 2019, Nature.
[74] S. Bernard,et al. Dynamics of oligodendrocyte generation in multiple sclerosis , 2019, Nature.
[75] Hongkui Zeng,et al. Multimodal cell type correspondence by intersectional mFISH in intact tissues , 2019, bioRxiv.
[76] H. Lassmann. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis , 2019, Front. Immunol..
[77] Sueli Marques,et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis , 2018, Nature Medicine.
[78] Vincent A. Traag,et al. From Louvain to Leiden: guaranteeing well-connected communities , 2018, Scientific Reports.
[79] Åsa K. Björklund,et al. Transcriptional Convergence of Oligodendrocyte Lineage Progenitors during Development , 2018, Developmental cell.
[80] Ole Kiehn,et al. Neuronal atlas of the dorsal horn defines its architecture and links sensory input to transcriptional cell types , 2018, Nature Neuroscience.
[81] Lars E. Borm,et al. Molecular Architecture of the Mouse Nervous System , 2018, Cell.
[82] H. Lassmann. Multiple Sclerosis Pathology. , 2018, Cold Spring Harbor perspectives in medicine.
[83] Li Li,et al. Massively Parallel Single Nucleus Transcriptional Profiling Defines Spinal Cord Neurons and Their Activity during Behavior , 2018, Cell reports.
[84] C. V. van Eden,et al. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis , 2018, Acta Neuropathologica.
[85] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[86] Loic A. Royer,et al. Content-aware image restoration: pushing the limits of fluorescence microscopy , 2018, bioRxiv.
[87] P. Morgan,et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions , 2016, Multiple sclerosis.
[88] Massimo Filippi,et al. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. , 2016, The Journal of clinical investigation.
[89] Jens Hjerling-Leffler,et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system , 2016, Science.
[90] E. Peles,et al. G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination , 2016, Nature Communications.
[91] Camille J. Olechowski,et al. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo , 2015, Journal of Neuroinflammation.
[92] A. Regev,et al. Spatial reconstruction of single-cell gene expression data , 2015 .
[93] S. Linnarsson,et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq , 2015, Science.
[94] F. Jacques. Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.
[95] Jeffrey A. Cohen,et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.
[96] T. Pozzan,et al. Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process , 2014, Cell Death and Differentiation.
[97] D. Holmberg,et al. Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis , 2013, PloS one.
[98] Carolina Wählby,et al. In situ sequencing for RNA analysis in preserved tissue and cells , 2013, Nature Methods.
[99] Michelle M. Giddens,et al. GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin , 2013, Proceedings of the National Academy of Sciences.
[100] J. Goverman,et al. Mechanisms regulating regional localization of inflammation during CNS autoimmunity , 2012, Immunological reviews.
[101] Steven M LeVine,et al. Pathogenic implications of iron accumulation in multiple sclerosis , 2012, Journal of neurochemistry.
[102] B. Scheithauer,et al. Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.
[103] A. Pachner. Experimental models of multiple sclerosis. , 2011, Current opinion in neurology.
[104] Xiaoyu Xia,et al. An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis , 2011, Brain pathology.
[105] Jullie W Pan,et al. DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI , 2008, Neurology.
[106] P. Sawchenko,et al. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis , 2007, The Journal of comparative neurology.
[107] Lisa K. Peterson,et al. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis , 2007, Journal of Neuroimmunology.
[108] S. Miller,et al. Interferon-γ-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis , 2007, The Journal of Neuroscience.
[109] T. Speed,et al. Functional Genomic Analysis of Oligodendrocyte Differentiation , 2006, The Journal of Neuroscience.
[110] J. Ting,et al. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.
[111] C. D. DE GROOT,et al. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS , 2000, Neuropathology and applied neurobiology.
[112] H. Lassmann,et al. Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology , 1998, Brain pathology.
[113] F. Dudek,et al. Grid‐mapped freeze‐fracture analysis of gap junctions in gray and white matter of adult rat central nervous system, with evidence for a “panglial syncytium” that is not coupled to neurons , 1997, The Journal of comparative neurology.
[114] A. Thompson,et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.
[115] A. Ben-nun,et al. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells , 1995, European journal of immunology.
[116] T. Olsson,et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.
[117] Alejandro F. Frangi,et al. Medical Image Computing and Computer Assisted Intervention – MICCAI 2018 , 2018, Lecture Notes in Computer Science.
[118] T. Olsson,et al. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis , 2017, Nature Reviews Neurology.
[119] Hans Lassmann,et al. An updated histological classification system for multiple sclerosis lesions , 2016, Acta Neuropathologica.
[120] F. Quintana,et al. [Immunopathology of multiple sclerosis]. , 2014, Medicina.
[121] U. Bogdahn,et al. Experimental autoimmune encephalomyelitis in the rat spinal cord: lesion detection with high-resolution MR microscopy at 17.6 T. , 2005, AJNR. American journal of neuroradiology.